Riyadh, Kingdom of Saudi Arabia; 10 September 2024: Following last year’s announcement of its ambitious international expansion plans, Avalon Pharmaceuticals has made significant
Tag: Avalon Pharma
Avalon Pharma Announces Launch of Pioneering New SFDA-approved Cough Syrup
Riyadh, KSA, 22 August 2024: Avalon Pharma, one of the fastest growing home-grown pharmaceutical companies in the Kingdom of Saudi Arabia, introduced an
Middle East Pharmaceutical Industries Company “Avalon Pharma” Announces its IPO Offer Price Range between SAR 78 – 82 per share
Riyadh, Saudi Arabia – 11 January 2024 – Middle East Pharmaceutical Industries Company “Avalon Pharma” , one of the fastest growing home-grown pharmaceutical manufacturing companies
